Provided by Tiger Trade Technology Pte. Ltd.

Global X Aging Population ETF

35.94
-0.1703-0.47%
Post-market: 35.91-0.0397-0.11%19:30 EDT
Volume:14.08K
Turnover:505.90K
Market Cap:87.35M
PE:- -
High:36.12
Open:36.12
Low:35.54
Close:36.12
52wk High:39.48
52wk Low:33.59
Shares:2.43M
Float Shares:2.43M
Volume Ratio:2.44
T/O Rate:0.58%
Dividend:0.33
Dividend Rate:0.92%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

WELL Health Technologies Corp (WELL) Gets a Buy from Stifel Nicolaus

TIPRANKS
·
Sep 23

Oruka Falls After Reporting Mid-Stage Data for Psoriasis Drug

Reuters
·
Sep 23

Welltower Schedules Third-Quarter Earnings Release and Conference Call

Reuters
·
Sep 23

Novo Nordisk Open to Direct New York Listing, CEO Doustdar Tells FT

Reuters
·
Sep 23

AbbVie Tells USTR Germany Drug Pricing Reforms Cut Innovative Medicine Value by Nearly 54%

Reuters
·
Sep 23

Eli Lilly Price Target Maintained with a $1250.00/Share by TD Cowen

Dow Jones
·
Sep 22

Viking Therapeutics Stock Surges 35%. It Could Challenge Lilly and Novo's Obesity Empire

Dow Jones
·
Sep 22

Analysts Have Conflicting Sentiments on These Healthcare Companies: Pyxis Oncology (PYXS), Moderna (MRNA) and Eli Lilly & Co (LLY)

TIPRANKS
·
Sep 22

Lucid Diagnostics advances Medicare reimbursement and coding infrastructure

TIPRANKS
·
Sep 22

I'm in My 50s. My Mother Died from Alzheimer's. Do I Need Long-Term-Care Insurance?

Dow Jones
·
Sep 22

Weight-Loss Drug Developers Line up to Tap Lucrative Market as Competition Heats Up

Reuters
·
Sep 22

Adagene Wins NMPA IND Clearance for Novel HER2xCD3 T-Cell Engager ADG138

TIPRANKS
·
Sep 22

Viking Therapeutics Stock Surges 36%. it Could Challenge Lilly and Novo's Obesity Empire.

Dow Jones
·
Sep 22

Roche Stock (RHHBY) Rises as New Obesity Drug Promises to Slash Weight By a Fifth

TIPRANKS
·
Sep 22

AbbVie: EC approves Rinvoq to treat polyarticular juvenile idiopathic arthritis

TIPRANKS
·
Sep 22

Shinva Medical Subsidiary Secures Class III Medical Device Approvals

Stock News
·
Sep 22

AbbVie Announces European Commission Approval of Rinvoq (Upadacitinib)

Reuters
·
Sep 22

AbbVie Says EU Approves Rinvoq for Children with Polyarticular Juvenile Idiopathic Arthritis

Reuters
·
Sep 22

Abbvie Announces European Commission Approval of Rinvoq® (Upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic Arthritis

THOMSON REUTERS
·
Sep 22

Abbvie - Rinvoq Approved in EU for Pjia in Patients Aged Two Years and Older

THOMSON REUTERS
·
Sep 22